金属配合物作为一氧化氮调节中的治疗剂。 - Suppr

Suppr

超能文献

Metal complexes as therapeutic agents in nitrogen monoxide modulation.

作者信息

Fricker Simon P

机构信息

AnorMED Inc., #200 20353, 64th Avenue, Langley, B.C., V2Y 1N5, Canada.

出版信息

Met Ions Biol Syst. 2004;41:421-80.

PMID:15206124

Abstract

摘要

相似文献

Metal complexes as therapeutic agents in nitrogen monoxide modulation.

Met Ions Biol Syst. 2004;41:421-80.

Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

Chem Asian J. 2008 Nov 13;3(11):1890-9. doi: 10.1002/asia.200800149.

Antitumor titanium compounds and related metallocenes.

Met Ions Biol Syst. 2004;42:353-84.

Photosensitization via dye coordination: a new strategy to synthesize metal nitrosyls that release NO under visible light.

J Am Chem Soc. 2007 May 2;129(17):5342-3. doi: 10.1021/ja070247x. Epub 2007 Apr 4.

Fluorescence-based nitric oxide detection by ruthenium porphyrin fluorophore complexes.

Inorg Chem. 2004 Oct 4;43(20):6366-70. doi: 10.1021/ic035418n.

Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules.

J Pharm Pharmacol. 2016 Mar;68(3):293-304. doi: 10.1111/jphp.12511. Epub 2016 Jan 15.

The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview.

J Pharmacol Exp Ther. 2022 Jan;380(1):47-53. doi: 10.1124/jpet.121.000798. Epub 2021 Nov 2.

Ruthenium complexes can target determinants of tumour malignancy.

Dalton Trans. 2007 Apr 7(13):1267-72. doi: 10.1039/b617769g. Epub 2007 Feb 28.

Ruthenium as an effective nitric oxide scavenger.

Curr Top Med Chem. 2004;4(15):1585-603. doi: 10.2174/1568026043387322.

Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.

Eur J Pharmacol. 2006 Mar 8;533(1-3):263-76. doi: 10.1016/j.ejphar.2005.12.069. Epub 2006 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Metal complexes as therapeutic agents in nitrogen monoxide modulation.

作者信息

Fricker Simon P

机构信息

AnorMED Inc., #200 20353, 64th Avenue, Langley, B.C., V2Y 1N5, Canada.

出版信息

Met Ions Biol Syst. 2004;41:421-80.

PMID:15206124

Abstract

摘要

相似文献

Metal complexes as therapeutic agents in nitrogen monoxide modulation.

Met Ions Biol Syst. 2004;41:421-80.

Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

Chem Asian J. 2008 Nov 13;3(11):1890-9. doi: 10.1002/asia.200800149.

Antitumor titanium compounds and related metallocenes.

Met Ions Biol Syst. 2004;42:353-84.

Photosensitization via dye coordination: a new strategy to synthesize metal nitrosyls that release NO under visible light.

J Am Chem Soc. 2007 May 2;129(17):5342-3. doi: 10.1021/ja070247x. Epub 2007 Apr 4.

Fluorescence-based nitric oxide detection by ruthenium porphyrin fluorophore complexes.

Inorg Chem. 2004 Oct 4;43(20):6366-70. doi: 10.1021/ic035418n.

Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules.

J Pharm Pharmacol. 2016 Mar;68(3):293-304. doi: 10.1111/jphp.12511. Epub 2016 Jan 15.

The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview.

J Pharmacol Exp Ther. 2022 Jan;380(1):47-53. doi: 10.1124/jpet.121.000798. Epub 2021 Nov 2.

Ruthenium complexes can target determinants of tumour malignancy.

Dalton Trans. 2007 Apr 7(13):1267-72. doi: 10.1039/b617769g. Epub 2007 Feb 28.

Ruthenium as an effective nitric oxide scavenger.

Curr Top Med Chem. 2004;4(15):1585-603. doi: 10.2174/1568026043387322.

Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.

Eur J Pharmacol. 2006 Mar 8;533(1-3):263-76. doi: 10.1016/j.ejphar.2005.12.069. Epub 2006 Feb 7.